Melissa Nixon is an Analytical Development Scientist at Piramal Pharma Solutions. She received her master’s degree in Pure and Applied Chemistry from the University of Strathclyde in 2017. After two years working with small molecules, she moved focus to antibody drug conjugates and joined Piramal Pharma Solutions in 2019.
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.